Company attributes
Location
Pitchbook URL
Founded Date
2010
Venture Capital Firm attributes
Invested in
Other attributes
Company Operating Status
Active
AT Impf is a venture capital firm in Munich, Germany that invests in the biotechnology and pharmaceutical sectors. Founded 2010 in Munich, Bayern, Germany, this venture capital company invests in Series C, Series D, Series E and other venture rounds. Its portfolio companies include Isarna Therapeutics and immatics biotechnologies. As of February 2020, AT Impf venture capital firm has made five investments. Their most recent investment was on Oct 4, 2017, when immatics biotechnologies raised $58M.
Timeline
No Timeline data yet.
Associated Investment Funds
Accelerator Batches
Funding Rounds
Products
Acquisitions
SBIR/STTR Awards
Patents
Funding Rounds Participated In
Further Resources
No Further Resources data yet.
